Rx PHARMASIST.CA
The Pharmasist newsletter

Stay current in
Canadian pharmacy.

Pharmacy news, practice updates and fresh perspectives—delivered to your inbox.

Keep your practice informed

  • Canadian pharmacy news

    Follow the developments shaping the profession.

  • Prescriber updates

    Stay informed about newly licensed Ontario physicians.

  • What's new on Pharmasist

    Explore new resources, tools and learning opportunities.

Free newsletter

A useful addition to your inbox.

We'll send a confirmation link first. Privacy policy

Vitamin D3 metabolite (active form of vitamin D)

Calcitriol

Rocaltrol

Dosage form
Tablet
Available strengths
0.25 mcg, 0.5 mcg
Drug class
Vitamin D3 metabolite (active form of vitamin D)
Common brand
Rocaltrol

Clinical overview. Calcitriol (brand name Rocaltrol) is the most active form of vitamin D3, used to correct low calcium levels in patients on dialysis, in hypoparathyroidism, and in vitamin D-resistant rickets. Because its therapeutic margin is narrow, dosing is individualized with frequent blood calcium monitoring to avoid hypercalcemia.

Indication

Common therapeutic uses

  • Calcitriol is used to treat low calcium levels and bone disease (osteodystrophy) in patients with chronic kidney failure who are on dialysis.
  • Calcitriol is used to treat low calcium levels caused by underactive parathyroid glands, whether from prior surgery, an unknown cause, or a condition where the body does not respond properly to parathyroid hormone (pseudohypoparathyroidism).
  • Calcitriol is used to treat vitamin D-resistant rickets, a type of bone disease caused by low blood phosphate (familial hypophosphatemia).

Pregnancy

Risk assessment and monitoring considerations

  • The safety of calcitriol in women who are or may become pregnant has not been established, so it should be used in pregnancy only after weighing the potential benefits against possible risks to the mother and baby.

Breastfeeding

Infant exposure considerations

  • Calcitriol may pass into breast milk, so mothers may continue breastfeeding while taking this medicine only if both the mother's and infant's blood calcium levels are monitored.

Geriatrics

Dosing and tolerability considerations

  • Only limited data exist in patients 65 and older, so this medicine should be used with caution in elderly patients, though no specific dose adjustment is required based on age alone.

Pediatrics

Use in children and adolescents

  • The safety and effectiveness of calcitriol capsules in children have not been sufficiently studied, so use in this age group is not recommended.

Dosage & Administration

Practical dosing and administration

  • For dialysis patients, the recommended starting dose is 0.25 mcg per day, increased by 0.25 mcg per day at two- to four-week intervals if needed, until an adequate response is seen; maintenance doses usually range from 0.25 mcg every other day up to 1 mcg per day.
  • For hypoparathyroidism and vitamin D-resistant rickets, the recommended starting dose is also 0.25 mcg per day, with increases of 0.25 mcg per day at two- to four-week intervals as needed; patients with malabsorption may need larger doses.
  • During dose titration, blood calcium levels should be checked at least twice weekly, and the drug should be stopped immediately if calcium levels become too high, until they return to normal.
  • Intermittent (pulse) dosing two or three times a week can be used and is effective even in some patients who do not respond to daily dosing.
  • If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose, in which case the missed dose should be skipped; extra doses should never be taken to make up for a missed one.

Overdose

Recognizing and responding to overdose

If overdose is suspected, seek emergency medical attention immediately or contact your regional Poison Control Centre without delay.

  • Taking more calcitriol than needed, or combining it with excess calcium or phosphate intake, can cause high blood calcium (hypercalcemia), high urine calcium, and high blood phosphate.
  • Management of hypercalcemia includes immediately stopping calcitriol, starting a low-calcium diet, and stopping calcium supplements, with daily blood calcium and phosphate checks until levels normalize; calcitriol may later be restarted at a lower dose once calcium levels return to normal.
  • For a recent accidental overdose, inducing vomiting or gastric lavage may help if discovered quickly, and mineral oil may be given to promote elimination of the drug if it has already passed through the stomach.
  • In dialysis patients, persistently high calcium levels may be corrected using dialysis against a calcium-free dialysate.
  • Electrocardiogram monitoring is important during overdose management, especially in patients also taking digitalis, since high calcium levels can trigger dangerous heart rhythm problems.

Common side effects

Frequently reported tolerability concerns

  • High blood calcium levels (hypercalcemia) are the most common side effect.
  • Headache may occur.
  • Nausea may occur.
  • Vomiting may occur.
  • Abdominal pain may occur.
  • Skin rash may occur.
  • Urinary tract infection may occur.
  • Decreased appetite may occur.
  • Constipation may occur.

Serious side effects

Findings that may require urgent assessment

Serious side effects require immediate discussion with the prescriber or emergency care.

  • Severe or prolonged high blood calcium can cause weakness, confusion, drowsiness, irregular heartbeat, excessive thirst, dry mouth, muscle pain, bone pain, and a metallic taste.
  • Ongoing high blood calcium can lead to calcium deposits in blood vessels, the kidneys, the cornea, and other soft tissues (calcinosis).
  • High blood calcium in patients taking digitalis, such as digoxin, can trigger dangerous heart rhythm disturbances.
  • Severe allergic reactions, including hives and, rarely, serious skin reactions, may occur.
  • Long-term high calcium can lead to excessive urination, increased thirst, weight loss, inflammation of the pancreas, and, rarely, psychosis.
  • A rise in serum creatinine, which is usually reversible, can occur with chronic high blood calcium.
  • Mood or behavior changes, including apathy, agitation, or insomnia, have been reported.
  • Muscle weakness or unusual skin sensations (sensory disturbances) may occur.
  • In children, growth retardation and limb pain have been reported, though use in this age group is not recommended.
  • Seek urgent medical attention for signs of severe high calcium, such as confusion, an irregular heartbeat, severe vomiting, or significant weakness.

Use with caution

Situations requiring closer assessment

  • Use with caution in patients taking digitalis medicines, since high calcium levels can trigger dangerous heart rhythms.
  • Use with caution in patients with normal kidney function, since chronic high calcium can raise creatinine levels.
  • Use with caution in patients on dialysis with a high dialysate calcium level or those taking excessive calcium supplements, since this increases the risk of hypercalcemia.
  • Use with caution and ensure adequate fluid intake, since dehydration increases the risk of complications.
  • Use with caution in elderly patients, who have limited safety data available.
  • Use with caution in patients with vitamin D-resistant rickets who continue oral phosphate therapy, since calcitriol may increase phosphate absorption and change phosphate supplement needs.
  • Use with caution — the product of serum calcium and phosphate (Ca x P) should be kept below 70 mg2/dl2 to reduce the risk of soft-tissue calcification.
  • Use with caution — patients should avoid unapproved over-the-counter medicines or supplements without checking with their healthcare professional first, since these could affect calcium balance.
  • Use with caution — periodic eye examinations and imaging of at-risk areas are advisable to detect early calcium deposits (ectopic calcification).

Contraindications

Situations where therapy may be inappropriate

  • Contraindicated in patients with known hypersensitivity to calcitriol, vitamin D, or any related derivative, or to any ingredient in the capsule.
  • Contraindicated in patients with high blood calcium (hypercalcemia) or evidence of vitamin D overdose.

Drug interactions

Clinically relevant combinations

  • Phenytoin or phenobarbital may reduce natural vitamin D levels in the body, so higher doses of calcitriol or additional vitamin D supplementation may be needed when these drugs are used together.
  • Cholestyramine, sevelamer, and mineral oil can reduce the absorption of calcitriol from the intestine.
  • Digitalis medicines combined with high calcium levels from calcitriol can increase the risk of dangerous heart rhythms.
  • Corticosteroids can counteract the calcium-absorbing effect of calcitriol.
  • Ketoconazole may interfere with the body's own processing of calcitriol.
  • Thiazide diuretics can reduce calcium loss in the urine and increase the risk of high blood calcium when combined with calcitriol.
  • Calcium supplements taken in uncontrolled amounts along with calcitriol increase the risk of high blood calcium.
  • Magnesium-containing products, such as some antacids, can cause high blood magnesium in dialysis patients taking calcitriol and should be avoided in this group.

Food interactions

Meal-related administration

  • Calcitriol capsules can be taken with or without food; however, patients must closely follow their prescribed dietary calcium intake, since this affects how the medicine works.

Time of administration

Practical scheduling

  • Calcitriol may be taken at any consistent time of day, with or without food, exactly as directed; some patients are prescribed an intermittent (pulse) schedule of two or three doses per week rather than a daily dose.

Storage

Product handling

  • Store calcitriol capsules at 15°C to 25°C, in the original container, protected from light and moisture, with the blister kept inside the outer carton.

Patient take-away

Key counselling points for a quick closing summary

  • Rocaltrol requires regular blood tests to monitor calcium, phosphate, and kidney function.
  • Follow your prescribed calcium intake carefully, and avoid taking extra calcium or vitamin D products without checking with your healthcare professional first.
  • Drink enough fluids to stay well hydrated while taking this medicine.
  • Report symptoms of high calcium, such as unusual thirst, frequent urination, confusion, or an irregular heartbeat, to your healthcare professional promptly.

References

Source material and product information

  1. Health Canada Product Monograph — Calcitriol

For professional reference. Confirm patient-specific decisions against the current approved product monograph and applicable clinical guidance.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.